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1. Introduction 
Several classes of antibiotic resistant mutant have 
been isolated in Paramecium aurelia, and have been 
shown by genetic analysis [l-3] and by micro-injec- 
tion techniques [4,5] to be due to alterations in the 
mitochondrial genome. One of these classes of mutant, 
resistant to high concentrations of erythromycin, has 
been shown to have altered mitochondrial ribosomes 
[6]. In yeast, a large number of mitochondrially 
inherited antibiotic resistant mutants have been shown, 
by use of the fragment reaction, to be due to alterations 
in the mitochondrial ribosomes [7,8]. Furthermore 
evidence has recently been obtained [9] suggesting 
that the gene for one of these mutants (resistant to 
erythromycin) is located in the ribosomal RNA cistron 
of mitochondrial DNA. 
Recently mitochondrial mutants resistant to mika- 
mycin and cross resistant to low levels of erythromy- 
tin have been isolated in Paramecium [ 51. In yeast, 
there is some evidence that mikamycin resistant 
mutants involve an alteration in the mitochondrial 
membrane [lo], although doubts have been raised 
about the validity of this conclusion [8]. It has also 
been suggested that other yeast mutants, resistant to 
spiramycin [ 111 and triethyltin [ 121 involve mito- 
chondrial membrane changes. 
In view of this, we thought it important to examine 
whether the mikamycin resistant Paramecium mutants 
involve changes in the mitochondrial ribosomes or in 
the mitochondrial membranes. Since the mutants were 
also resistant to a low level of erythromycin we were 
able to study this question by erythromycin binding 
experiments. 
North-Holland Publishing Company - Amsterdam 
2. Materials and methods 
The stocks used were 5 13 sensitive, and two spon- 
taneous mutants 513 ER-48 and 5 13 ER-0 18 belonging 
to syngen (species) 1 of P. aurelia. As previously 
described [ 51, 5 13 ER-48 is resistant to 250 pg/ml 
erythromycin while 5 13 ER-01 8 is resistant to only 
125 mg/ml erythromycin and also to 250 pg/ml mika- 
mycin. The cells were cultured and mitochondria pre- 
pared as described previously [6], except that 0.44 M 
mannitol, 1 mM MOPS, 0.25% BSA, pH = 7.2 was 
used as a homogenisation buffer. 
Mitochondrial ribosomes were prepared from 
mitochondrial pellets by two methods: 
(i) Mitochondria were homogenised in 2 ml of 2% 
Triton X-l 00 in TMK/heparin (50 mM Tris-HCl, 
10 mM MgClz , 10 mM KCl, 1 mglml heparin) and 
left for 30 min. at 0°C. The lysate was centrifuged at 
15 000 g for 20 min, the supernatant removed and 
centrifuged at 180 000 g for 90 min. The resulting 
pellet of ‘crude’ ribosomes was resuspended in TMN 
(50 mM Tris-HCl, 10 mM magnesium acetate, 40 mM 
NH, Cl, pH = 7.2) and 12.0 A sW units used for esti- 
mating erythromycin binding. 
(ii) The ‘crude’ ribosome preparation obtained above 
was resuspended in TMK and puromycin and KCl 
added to final concentrations of 1 mM and 500 mM 
respectively. This suspension was incubated at 27°C 
for 10 minutes, layered on a 2.5 ml 20% sucrose/TMK 
cushion, centrifuged at 130 000 g for 40 min and the 
supernatant and sucrose layer removed. This was 
diluted 1: 1 with TMK and the ribosomes centrifuged 
at 180 000 g for 90 min, the final pellet being resus- 
pended in TMN for erythromycin binding estimations. 
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The amount of erythromycin bound to mitochon- 
drial ribosomes was determined using: (1) whole mito- 
chondria and (2) isolated ribosomes. Experiments 
were performed to determine the optimal conditions 
and these are given in the legends to the figure and 
tables. After the binding reaction was completed, the 
amount of labelled erythromycin was estimated by 
precipitating the ribosome-antibiotic complex with 
cold (-20°C) ethanol/40 mM N&Cl. The resulting 
precipitate was centrifuged, washed twice in ethanol/ 
40 mM NH4Cl and resuspended in 0.4 ml NH40H. This 
suspension was mixed with toluene and solubilizer and 
counted in a liquid scintillation counter. All counts 
are given with background subtracted. 
3. Results 
In order to examine whether the drug resistance 
could be observed in isolated mitochondria, erythro- 
mycin binding to the mitochondrial ribosomes was 
measured after incubation of mitochondria in [ l4 C] - 
methyl erythromycin. Fig. 1 shows the results of such 
an experiment for the three stocks 513S, 5 13 ER-48 
and 5 13 ER-01 8. The mean values (and standard 
errors) from several experiments are given in fig. 1 A. 
It can be seen that the binding of erythromycin is 
reduced in both mutants, but that the ‘low’ resistant 
mutant (ER-018) binds more erythromycin than the 
‘high’ resistant mutant. The results from one experi- 
ment are presented in fig. 1 B, where the binding to 
three samples of each type of stock are shown. 
A. 
Stock s E’018 E’48 
cPm 151k8.7 77k3.7 1 35*3.7 
l * 
% of s 100 
51 ** i 23 
No Exps 9 8 I 6 
0. 
5 1 3-s 51 3E’-01 8 5 1 3 Er-48 
Fig. 1. Binding of [ I4 C] methyl erythromycin to mitochondrial 
ribosomes after incubation of whole mitochondria on 0.44 
mannitol, 1 mM MOPS, 10 mM K,HPO,, 4 mM MgCI,, 10 
mM KCI, 200 mM succinic acid, 10 mM ADP, 0.2% BSA, pH 
= 7.2, 0.433 &i [t4C] methyl erythromycin (9.45 Ci/mg) for 
10 min at 30°C. The reaction mixture was cooled, diluted 
with ‘cold’ incubation buffer and centrifuged at 10 000 g for 
10 min. Mitochondrial ribosomes were then prepared and 
counted as described. (A) Mean of cpm bound f standard 
error for several experiments. (B) cpm Bound for three sam- 
ples of ribosomes prepared from each type of stock. 
Table 1 
Binding of erythromycin to isolated ‘crude’ ribosomes (A) and purer ribosomes (B) 
A. Ribosomes from [I4 C) methyl erythromycin %of 513s concentration 
stock bound (cpm/l2 &,) binding of erythromycin 
513s 300 f 21.5 100 0.25 x 1O-5 M 
513 ER-018 148 + 28.9 49.5 0.25 X 10-s M 
513 ER-48 72 5 32.7 24 0.25 X 10-s M 
B. 513s 389 f 30.3 100 0.25 X 10-s M 
513 ER-018 269 * 25.5 69 0.25 x 1O-5 M 
513 ER-48 42 * 4.7 11 0.25 x 10-s M 
The figures are given as means of several experiments f standard error. The ribosomes were incubated in 
TMN buffer at 48 A,,, units/ml with 0.0344 &i [“Cl methyl erythromycin/ml for 10 min at 30°C. The 
erythromycin bound was estimated as described. 
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These results show that the resistant phenotype is 
exhibited in vitro with whole mitochondria, and corre- 
sponds to the degree of resistance of whole paramecia 
observed in vivo. The reduced binding by the ribosomes 
could be due either to an alteration in the permeability 
of the membrane to erythromycin or an alteration in 
the ribosomes themselves. For the 5 13 ER-48 strain 
Tait [6], using slightly different techniques, has shown 
that the alteration resides in the ribosomes and not in 
the membrane. 
In order to test whether ER-01 8 ribosomes also 
have altered erythromycin binding, a quantitative 
assay of erythromycin binding to isolated ribosomes 
was developed, based on that used with bacterial 
ribosomes [ 131. The results of such experiments with 
ribosomes from all three stocks are shown in table 1 A 
and B. In both sets of results it is clear that the ribo- 
somes from both ER-018 and ER-48 show reduced 
binding of erythromycin, although the amount bound 
to ER-01 8 ribosomes was considerably higher than 
that to ER-48. The results presented in table 1A were 
obtained using ‘crude’ ribosomal preparations (method 
(i)) which almost certainly contain membrane frag- 
ments to which a considerable fraction of the ribo- 
somes were still bound (Tait, unpublished observations). 
If an alteration occurred in one of the membrane 
proteins this could, by its close association with the 
ribosome, alter the binding properties of the ribosome. 
For this reason, these experiments were repeated with 
purer preparations of ribosomes (method (ii)) as shown 
in table 1B. Again, it is clear that the binding of 
erythromycin to ER-01 8 ribosomes is reduced com- 
pared to the binding to sensitive ribosomes. 
A possible error in the interpretation of these 
results would arise if the presumed mitochondrial 
ribosome preparations were differentially contaminated 
with bacterial or cytoplasmic ribosomes. This inter- 
pretation is excluded by two sets of experiments. 
Firstly, sucrose density gradient centrifugation of 
preparations similar to those used above do not show 
any ribosome peaks with the S-values of cytoplasmic 
or bacterial ribosomes. Secondly antisera raised against 
the mitochondrial ribosome preparations did not react 
with either bacterial or cytoplasmic ribosome prepa- 
rations. 
Some irregularities in the behaviour of stock 5 13 
ER-01 8 were observed, and are under study. After 
mass culturing this stock in the absence of erythro- 
mycin for a considerable time, it was found that the 
isolated mitochondrial ribosomes were apparently 
indistinguishable from sensitive ribosomes when tested 
for erythromycin binding. When whole cells from such 
cultures were tested for resistance to erythromycin 
they were found to show the sensitive phenotype. 
However, after re-isolation and growth under optimal 
conditions, or brief exposure to erythromycin, these 
cells rapidly regained their typical resistant pheno- 
type. These results could not have been explained in 
terms of a genetic reversion, in view of the complete 
and rapid re-aquisition of resistance. It appears that 
this mutant is prone to show fluctuations in resistance 
to erythromycin under sub-optimal growth conditions, 
and these fluctuations affect the binding of erythro- 
mycin to the isolated ribosomes. 
4. Discussion 
The results presented in this paper show clearly 
that both classes of cytoplasmically inherited erythro- 
mycin resistant mutant (5 13 ER-48 and 5 13 ER-01 8) 
one of which is also mikamycin resistant, have altered 
mitochondrial ribosomes. These differences are shown 
irrespective of whether the ribosomes examined are 
in intact mitochondria or in a purified preparation and 
thus preclude the possibility of the resistance being 
due to a membrane alteration. 
Our results are in agreement with those from 
studies on various low level erythromycin resistant 
mutants in yeast [8], where it has been shown that an 
alteration in the mitochondrial ribosomes was the 
basis for the aquisition of the resistant phenotype. 
Bunn et al. [lo] have obtained mikamycin resistant 
mutants in yeast and have suggested, from their data, 
that some of these are due to alterations in the mito- 
chondrial membranes. While it is perhaps unwise to 
compare results from different organisms, we have not 
been able to find membrane alterations in mikamycin 
resistant mutants in Paramecium. Our finding that the 
mitochondrial ribosomes of the mutant 5 13 ER-01 8 
(also mikamycin resistant), obtained from paramecia 
grown under sub-optimal conditions in the absence of 
drug, apparently exhibited an erythromycin sensitive 
phenotype show that it is sometimes easy to conclude, 
albeit erroneously, that an antibiotic resistant mutant 
could be due to membrane permeability changes. 
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